You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MSS

Showing 1 - 25 of 920
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MSS, Rectal Cancer Trial (Sintilimab with Interleukin-2)

Not yet recruiting
  • MSS
  • Rectal Cancer
  • Sintilimab with Interleukin-2
  • (no location specified)
Nov 1, 2023

Tislelizumab, Bevacizumab, Oxaliplatin Trial in Beijing (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Recruiting
  • Tislelizumab
  • +7 more
  • Beijing, China
    Lin Yang
Jul 21, 2023

Locally Advanced, High-Risk, Rectal Cancer Trial in Guangzhou (Toripalimab, short-term radiotherapy, Oxaliplatin)

Not yet recruiting
  • Locally Advanced
  • +3 more
  • Guangzhou, Guangdong, China
    Nanfang Hospital Southern Medical University
May 17, 2023

Colorectal Liver Metastases Trial in Nanjing (Radiation: High- and Low-dose radiotherapy, PD-1 Inhibitors)

Recruiting
  • Colorectal Liver Metastases
  • Radiation: High- and Low-dose radiotherapy
  • PD-1 Inhibitors
  • Nanjing, Jiangsu, China
    Jiangsu Cancer Hospital
Sep 13, 2023

Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal

Completed
  • Colorectal Cancer
  • Fruquintinib combined with anti-PD-1 antibodies
  • ChangSha, Hunan, China
    Hunan Cancer Hospital
Aug 27, 2023

Colon Tumor Trial in Hangzhou (Oxaliplatin, Capecitabine, Anti-PD-L1 Monoclonal Antibody)

Not yet recruiting
  • Colon Neoplasm
  • Hangzhou, Zhejiang, China
    Second Affiliated Hospital of Zhejiang University School of Medi
Jun 25, 2023

Colorectal Cancer Trial (cadonilimab, irinotecan, Oxaliplatin)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Apr 20, 2023

Bevacizumab Combined With PD-1 Monoclonal Antibody in

Not yet recruiting
  • Colorectal Cancer
  • Bevacizumab Combined With PD-1 Monoclonal Antibody
  • (no location specified)
Nov 8, 2023

Testicular Sperm Aspiration vs. Microfluidic Sperm Separation

Active, not recruiting
  • Infertility, Male
  • +2 more
    • Montreal, Quebec, Canada
      Clinique Ovo
    May 18, 2023

    Locally Advanced Colorectal Carcinoma Trial in Beijing (Cadonilimab, FOLFOX regimen)

    Recruiting
    • Locally Advanced Colorectal Carcinoma
    • Beijing, Beijing, China
      Cancer Hospital/ National Cancer Center, Chinese Academy of Medi
    Nov 23, 2023

    Low Rectal Cancer Trial in Hanzhou (Modified short-course radiotherapy, PD-1 antibody, Capecitabine)

    Not yet recruiting
    • Low Rectal Cancer
    • Modified short-course radiotherapy
    • +3 more
    • Hanzhou, Zhejiang, China
      Sir Run Run Shao hospital
    Jul 31, 2023

    Locally Advanced Rectal Cancer Trial in Beijing (capecitabine, tislelizumab, thymalfasin)

    Not yet recruiting
    • Locally Advanced Rectal Cancer
    • Beijing, China
    • +1 more
    Sep 21, 2023

    Rectal Cancer Trial in Hangzhou (Envafolimab)

    Not yet recruiting
    • Rectal Cancer
    • Envafolimab
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
    Mar 1, 2023

    Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Cetuximab + Envafolimab + mFOLFOXIRI
    • Cetuximab + mFOLFOX6/FOLFIRI
    • (no location specified)
    Jul 24, 2023

    Rectal Cancer Trial in Hangzhou (Envafolimab)

    Recruiting
    • Rectal Cancer
    • Hangzhou, Zhejiang, China
      Sir Run Run Shaw Hospital, Zhejiang University School of Medicin
    May 4, 2023

    Metastatic Colorectal Cancer, mCRC Trial in Guangzhou (Tislelizumab & Fruquintinib)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • mCRC
    • Tislelizumab & Fruquintinib
    • Guangzhou, Guangdong, China
    • +1 more
    Jan 25, 2023

    Colorectal Tumors Trial (Envafolimab, recombinant human endostatin (endostatin))

    Not yet recruiting
    • Colorectal Neoplasms
    • (no location specified)
    Sep 19, 2022

    Locally Advanced Colorectal Cancer Trial (Capecitabine, Oxaliplatin, Bevacizumab)

    Not yet recruiting
    • Locally Advanced Colorectal Cancer
    • (no location specified)
    Oct 18, 2022

    Colorectal Cancer Liver Metastases Trial (CapOx(Capecitabine+ Oxaliplatin), Bevacizumab, Nivolumab)

    Not yet recruiting
    • Colorectal Cancer Liver Metastases
    • CapOx(Capecitabine+ Oxaliplatin)
    • +2 more
    • (no location specified)
    Oct 18, 2022

    Neoadjuvant Chemoradiation Therapy, Rectal Cancer, Immunotherapy Trial in Shanghai (xintilimab injection, Control)

    Recruiting
    • Neoadjuvant Chemoradiation Therapy
    • +3 more
    • xintilimab injection
    • Control
    • Shanghai, Shanghai, China
      Department of Colorectal Surgery in Changhai Hospital
    Aug 5, 2022

    Colorectal Cancer Trial (KN046, regorafenib)

    Not yet recruiting
    • Colorectal Cancer
    • (no location specified)
    Aug 2, 2023

    New Patient Stratification Tools in MSS RAS mt mCRC

    Completed
    • Advanced Colorectal Cancer
      • Heidelberg, Germany
      • +9 more
      Nov 25, 2022

      Colorectal Cancer, Liver Metastases, MSS Trial (Sinti+Rego+Cele)

      Not yet recruiting
      • Colorectal Cancer
      • +2 more
      • (no location specified)
      Jul 3, 2023

      Advanced Rectal Cancer, Liver Metastasis, Pulmonary Metastasis Trial in Shanghai (a combination therapy)

      Not yet recruiting
      • Advanced Rectal Cancer
      • +3 more
      • a combination therapy including tislelizumab
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer Center
      Nov 9, 2022

      Colonic Tumors, Neoadjuvant Therapy, Immune Checkpoint Inhibitors Trial in Nanning (Tislelizumab, Oxaliplatin, Capecitabine)

      Recruiting
      • Colonic Neoplasms
      • +2 more
      • Nanning, Guangxi, China
        The First Affiliated Hospital of Guangxi Medical University
      Nov 9, 2023